COSTA MESA, Calif.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (OTCBB:OXBO) has posted an Update on the company website that discusses the company’s development plans for Oxycyte®. Oxycyte is the company's perfluorocarbon (PFC) therapeutic oxygen carrier.
